Travoprost is a Medicine belongs to Prostaglandin analogues group whose information about Brand can be referenced from   Book : Martindale    Page : 2012   Edition : 38,

  ►   Brandname : Lupitros,Travatan

  ►  Strength : Ophthalmic Solution with 0.004  %,

Reference of this Medicine for its Strength can be taken from   Book : Basic & Clinical pharmacology    Page : 328   Edition : 12,
A Route of administration in pharmacology and toxicology is the path by which a drug, fluid, poison, or other substance is taken into the body. Routes of administration are generally classified by the location at which the substance is applied. Common examples include oral and intravenous administration.

  ►  Route of administration : Topical,
Reference :-   Book : Martindale    Page : 2012   Edition : 38,

Dosing of Medicine differ in Adult & Pediatrics ↓


Adult Dose

S.No Ailment   Route   Dose Min   Dose Max   Unit   Dosage Form   Frequency   Additional Info
1 Open-angle glaucoma ophthalmic 0.004 % Solution o.d.
2 Ocular hypertension ophthalmic 0.004 % Solution o.d.

Ref :-  Book : Martindale    Page : 2012   Edition : 38,




Pediatric Dose

S.No Ailment   Age Min   Age Max   Weight ( Kg ) Route   Dose Min   Dose Max   Unit   Dosage Form   Frequency  Additional Info  

Ref :- Book :
►  Side Effect : irreversible brown pigmentation of the iris, eyelashes, drying of the eyes, conjunctivitis, Macular retinal edema, Blurred Vision,
Ref :-   Book : Basic & Clinical pharmacology    Page : 328   Edition : 12,

►  Drug Interaction : Drug interaction of Travoprost is with NA

  ►    Mechanism of Drug Drug Interaction :  NF,
Ref :-   Book :    Page :    Edition : ,


►  Contraindication : Hypersensivity to other group members,
Ref :-   Book : Principle of Pharmacology (The Pathophysiologic Basis of Drug Therapy)    Page : 763   Edition : 3,
  ►  Mechanism of Action :   Travoprost, bind to FP receptors that link to Gq11 and then to the PLC–IP3–Ca2+ pathway. This pathway is active in isolated human ciliary muscle cells. Other cells in the eye also may express FP receptors. Theories of IOP lowering by PGF2 range from altered ciliary muscle tension to effects on trabecular meshwork cells to release of matrix metalloproteinases and digestion of extracellular matrix materials that may impede outflow tracts. ,
Ref :-   Book : Goodman    Page : 1787   Edition : 12,

Pathway of Dietry Product


​   ► Act.Comp / Nutrient / Food / Herb as follows :- NA


Dietry Substance Interactions


​   ► This Medicine interact with :- NA



ContraIndication Dietry Substance


​   ► This Medicine contraindicate with :- NA

►   Route of Elimination :   NA


►    Plasma Half-life :
  Min value :-   NA    Max value :-   NA


►    Peak Plasma Concentration :   Min value :-   NA    Max value :-   NA